Parkwood LLC Axsome Therapeutics, Inc. Transaction History

Parkwood LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $421,114 - $613,406	-7,532 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $144,688 - $188,786	-2,182 Reduced 22.46%	7,532 $614,000
Q3 2020 Nov 12, 2020	SELL	$68.34 - $85.84 $187,661 - $235,716	-2,746 Reduced 22.04%	9,714 $1.1 Million
Q2 2020 Aug 11, 2020	BUY	$49.87 - $98.69 $621,380 - $1.23 Million	12,460 New	12,460 $1.03 Million

328

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.42B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.